Logo image of BDX

BECTON DICKINSON AND CO (BDX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BDX - US0758871091 - Common Stock

195.36 USD
-1.03 (-0.52%)
Last: 12/17/2025, 8:04:00 PM
195.36 USD
0 (0%)
After Hours: 12/17/2025, 8:04:00 PM
Fundamental Rating

5

Overall BDX gets a fundamental rating of 5 out of 10. We evaluated BDX against 187 industry peers in the Health Care Equipment & Supplies industry. BDX scores excellent on profitability, but there are some minor concerns on its financial health. BDX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BDX was profitable.
BDX had a positive operating cash flow in the past year.
BDX had positive earnings in each of the past 5 years.
BDX had a positive operating cash flow in each of the past 5 years.
BDX Yearly Net Income VS EBIT VS OCF VS FCFBDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

The Return On Assets of BDX (3.03%) is better than 77.54% of its industry peers.
BDX has a better Return On Equity (6.61%) than 80.75% of its industry peers.
BDX has a better Return On Invested Capital (6.24%) than 79.68% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BDX is below the industry average of 8.82%.
The last Return On Invested Capital (6.24%) for BDX is above the 3 year average (5.64%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.03%
ROE 6.61%
ROIC 6.24%
ROA(3y)2.9%
ROA(5y)3.12%
ROE(3y)6.24%
ROE(5y)6.77%
ROIC(3y)5.64%
ROIC(5y)5.24%
BDX Yearly ROA, ROE, ROICBDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 7.68%, BDX is in the better half of the industry, outperforming 79.14% of the companies in the same industry.
BDX's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 15.70%, BDX belongs to the best of the industry, outperforming 85.03% of the companies in the same industry.
In the last couple of years the Operating Margin of BDX has grown nicely.
BDX's Gross Margin of 45.79% is on the low side compared to the rest of the industry. BDX is outperformed by 61.50% of its industry peers.
BDX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.7%
PM (TTM) 7.68%
GM 45.79%
OM growth 3Y4.99%
OM growth 5Y10.71%
PM growth 3Y-4.96%
PM growth 5Y10%
GM growth 3Y0.22%
GM growth 5Y0.65%
BDX Yearly Profit, Operating, Gross MarginsBDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

4

2. Health

2.1 Basic Checks

BDX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BDX has been reduced compared to 1 year ago.
Compared to 5 years ago, BDX has less shares outstanding
Compared to 1 year ago, BDX has an improved debt to assets ratio.
BDX Yearly Shares OutstandingBDX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
BDX Yearly Total Debt VS Total AssetsBDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.2 Solvency

BDX has an Altman-Z score of 2.16. This is not the best score and indicates that BDX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of BDX (2.16) is better than 62.03% of its industry peers.
BDX has a debt to FCF ratio of 7.18. This is a slightly negative value and a sign of low solvency as BDX would need 7.18 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.18, BDX is in the better half of the industry, outperforming 75.40% of the companies in the same industry.
A Debt/Equity ratio of 0.73 indicates that BDX is somewhat dependend on debt financing.
BDX's Debt to Equity ratio of 0.73 is on the low side compared to the rest of the industry. BDX is outperformed by 68.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 7.18
Altman-Z 2.16
ROIC/WACC0.86
WACC7.23%
BDX Yearly LT Debt VS Equity VS FCFBDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 1.11 indicates that BDX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.11, BDX is not doing good in the industry: 86.10% of the companies in the same industry are doing better.
A Quick Ratio of 0.64 indicates that BDX may have some problems paying its short term obligations.
BDX has a Quick ratio of 0.64. This is amonst the worse of the industry: BDX underperforms 89.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.64
BDX Yearly Current Assets VS Current LiabilitesBDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

4

3. Growth

3.1 Past

BDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.57%, which is quite good.
BDX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.19% yearly.
The Revenue has grown by 8.24% in the past year. This is quite good.
Measured over the past years, BDX shows a small growth in Revenue. The Revenue has been growing by 6.32% on average per year.
EPS 1Y (TTM)9.57%
EPS 3Y5.64%
EPS 5Y7.19%
EPS Q2Q%3.94%
Revenue 1Y (TTM)8.24%
Revenue growth 3Y4.99%
Revenue growth 5Y6.32%
Sales Q2Q%8.33%

3.2 Future

The Earnings Per Share is expected to grow by 7.68% on average over the next years.
The Revenue is expected to grow by 3.70% on average over the next years.
EPS Next Y4.05%
EPS Next 2Y4.84%
EPS Next 3Y5.85%
EPS Next 5Y7.68%
Revenue Next Year2.9%
Revenue Next 2Y3.15%
Revenue Next 3Y3.22%
Revenue Next 5Y3.7%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BDX Yearly Revenue VS EstimatesBDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BDX Yearly EPS VS EstimatesBDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.55, which indicates a correct valuation of BDX.
88.77% of the companies in the same industry are more expensive than BDX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.22, BDX is valued a bit cheaper.
The Price/Forward Earnings ratio is 13.02, which indicates a correct valuation of BDX.
90.37% of the companies in the same industry are more expensive than BDX, based on the Price/Forward Earnings ratio.
BDX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.58.
Industry RankSector Rank
PE 13.55
Fwd PE 13.02
BDX Price Earnings VS Forward Price EarningsBDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BDX is valued cheaply inside the industry as 86.10% of the companies are valued more expensively.
BDX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BDX is cheaper than 87.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.88
EV/EBITDA 12.47
BDX Per share dataBDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BDX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.34
PEG (5Y)1.88
EPS Next 2Y4.84%
EPS Next 3Y5.85%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.10%, BDX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 0.19, BDX pays a better dividend. On top of this BDX pays more dividend than 96.79% of the companies listed in the same industry.
BDX's Dividend Yield is comparable with the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 2.1%

5.2 History

The dividend of BDX has a limited annual growth rate of 3.22%.
BDX has been paying a dividend for at least 10 years, so it has a reliable track record.
BDX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.22%
Div Incr Years34
Div Non Decr Years34
BDX Yearly Dividends per shareBDX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

71.28% of the earnings are spent on dividend by BDX. This is not a sustainable payout ratio.
The dividend of BDX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP71.28%
EPS Next 2Y4.84%
EPS Next 3Y5.85%
BDX Yearly Income VS Free CF VS DividendBDX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
BDX Dividend Payout.BDX Dividend Payout, showing the Payout Ratio.BDX Dividend Payout.PayoutRetained Earnings

BECTON DICKINSON AND CO

NYSE:BDX (12/17/2025, 8:04:00 PM)

After market: 195.36 0 (0%)

195.36

-1.03 (-0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-03 2026-02-03
Inst Owners94.16%
Inst Owner Change4.07%
Ins Owners0.56%
Ins Owner Change5.2%
Market Cap55.76B
Revenue(TTM)21.84B
Net Income(TTM)1.68B
Analysts72.22
Price Target207.83 (6.38%)
Short Float %1.69%
Short Ratio2.17
Dividend
Industry RankSector Rank
Dividend Yield 2.1%
Yearly Dividend4.16
Dividend Growth(5Y)3.22%
DP71.28%
Div Incr Years34
Div Non Decr Years34
Ex-Date12-08 2025-12-08 (1.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.54%
Min EPS beat(2)-0.05%
Max EPS beat(2)7.13%
EPS beat(4)3
Avg EPS beat(4)5.56%
Min EPS beat(4)-0.05%
Max EPS beat(4)14.05%
EPS beat(8)7
Avg EPS beat(8)5.42%
EPS beat(12)10
Avg EPS beat(12)4.67%
EPS beat(16)13
Avg EPS beat(16)5.77%
Revenue beat(2)0
Avg Revenue beat(2)-0.9%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)-0.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.99%
Min Revenue beat(4)-2.51%
Max Revenue beat(4)0.37%
Revenue beat(8)2
Avg Revenue beat(8)-0.95%
Revenue beat(12)5
Avg Revenue beat(12)-0.43%
Revenue beat(16)6
Avg Revenue beat(16)-0.46%
PT rev (1m)-6.3%
PT rev (3m)-6.61%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)-12.23%
EPS NY rev (1m)0.11%
EPS NY rev (3m)-0.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.65%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-1.73%
Valuation
Industry RankSector Rank
PE 13.55
Fwd PE 13.02
P/S 2.55
P/FCF 20.88
P/OCF 16.26
P/B 2.2
P/tB N/A
EV/EBITDA 12.47
EPS(TTM)14.42
EY7.38%
EPS(NY)15
Fwd EY7.68%
FCF(TTM)9.35
FCFY4.79%
OCF(TTM)12.02
OCFY6.15%
SpS76.52
BVpS88.96
TBVpS-37.23
PEG (NY)3.34
PEG (5Y)1.88
Graham Number169.89
Profitability
Industry RankSector Rank
ROA 3.03%
ROE 6.61%
ROCE 7.29%
ROIC 6.24%
ROICexc 6.33%
ROICexgc 26.66%
OM 15.7%
PM (TTM) 7.68%
GM 45.79%
FCFM 12.23%
ROA(3y)2.9%
ROA(5y)3.12%
ROE(3y)6.24%
ROE(5y)6.77%
ROIC(3y)5.64%
ROIC(5y)5.24%
ROICexc(3y)5.8%
ROICexc(5y)5.4%
ROICexgc(3y)27.15%
ROICexgc(5y)27.08%
ROCE(3y)6.53%
ROCE(5y)6.07%
ROICexgc growth 3Y-3.96%
ROICexgc growth 5Y9.78%
ROICexc growth 3Y7.94%
ROICexc growth 5Y16.75%
OM growth 3Y4.99%
OM growth 5Y10.71%
PM growth 3Y-4.96%
PM growth 5Y10%
GM growth 3Y0.22%
GM growth 5Y0.65%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 7.18
Debt/EBITDA 3.14
Cap/Depr 30.87%
Cap/Sales 3.48%
Interest Coverage 5.46
Cash Conversion 58.23%
Profit Quality 159.12%
Current Ratio 1.11
Quick Ratio 0.64
Altman-Z 2.16
F-Score7
WACC7.23%
ROIC/WACC0.86
Cap/Depr(3y)33.59%
Cap/Depr(5y)39.6%
Cap/Sales(3y)3.86%
Cap/Sales(5y)4.6%
Profit Quality(3y)162.63%
Profit Quality(5y)151.73%
High Growth Momentum
Growth
EPS 1Y (TTM)9.57%
EPS 3Y5.64%
EPS 5Y7.19%
EPS Q2Q%3.94%
EPS Next Y4.05%
EPS Next 2Y4.84%
EPS Next 3Y5.85%
EPS Next 5Y7.68%
Revenue 1Y (TTM)8.24%
Revenue growth 3Y4.99%
Revenue growth 5Y6.32%
Sales Q2Q%8.33%
Revenue Next Year2.9%
Revenue Next 2Y3.15%
Revenue Next 3Y3.22%
Revenue Next 5Y3.7%
EBIT growth 1Y18.62%
EBIT growth 3Y10.23%
EBIT growth 5Y17.71%
EBIT Next Year20.57%
EBIT Next 3Y11.99%
EBIT Next 5Y12.28%
FCF growth 1Y-13.11%
FCF growth 3Y17.14%
FCF growth 5Y-0.73%
OCF growth 1Y-9.69%
OCF growth 3Y9.2%
OCF growth 5Y-0.62%

BECTON DICKINSON AND CO / BDX FAQ

Can you provide the ChartMill fundamental rating for BECTON DICKINSON AND CO?

ChartMill assigns a fundamental rating of 5 / 10 to BDX.


Can you provide the valuation status for BECTON DICKINSON AND CO?

ChartMill assigns a valuation rating of 6 / 10 to BECTON DICKINSON AND CO (BDX). This can be considered as Fairly Valued.


How profitable is BECTON DICKINSON AND CO (BDX) stock?

BECTON DICKINSON AND CO (BDX) has a profitability rating of 7 / 10.


What is the financial health of BECTON DICKINSON AND CO (BDX) stock?

The financial health rating of BECTON DICKINSON AND CO (BDX) is 4 / 10.


What is the expected EPS growth for BECTON DICKINSON AND CO (BDX) stock?

The Earnings per Share (EPS) of BECTON DICKINSON AND CO (BDX) is expected to grow by 4.05% in the next year.